Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 37 matching records.
37 results — page 1 of 2
- Level DNarrative ReviewPubMed
Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions.
Narrative Review on Autoimmune Research, published in MedComm (2020) (2026) — summary generated from the PubMed abstract.
- 2026
MedComm (2020) - Level BClinical TrialEurope PMC
Mapping the landscape and future directions of stem cell therapy for inflammatory bowel disease
Clinical Trial on Scar, Autoimmune Research, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level DNarrative ReviewEurope PMC
Exosomes in Inflammatory Bowel Disease: Mechanisms, Diagnostic Potential, and Engineering Strategies for Precision Therapy
Narrative Review on Immune Modulation, published in Int J Med Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Med Sci - Level DNarrative ReviewEurope PMC
Extracellular Vesicles and Their Role in Skin Inflammatory Diseases: From Pathogenesis to Therapy
Narrative Review on Chronic Wound, Immune Modulation, Autoimmune Research, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
Int J Mol Sci10 citations - Level AMeta-analysisPubMed
Efficacy and safety of culture-expanded mesenchymal stromal cell therapy in the treatment of 4 types of inflammatory arthritis: A systematic review and meta-analysis of 36 randomized controlled trials.
Meta-analysis with a reported sample of 76 on Osteoarthritis, Autoimmune Research, published in Semin Arthritis Rheum (2024) — summary generated from the PubMed abstract.
- 2024
- n = 76
Semin Arthritis Rheum - Level DAnimal StudyPubMed
Dampened inflammatory response in oral ulcer after topical therapy of adipose mesenchymal stem cell secretome.
Animal Study on Chronic Wound, Chronic Inflammation, Immune Modulation, published in J Taibah Univ Med Sci (2024) — summary generated from the PubMed abstract.
- 2024
J Taibah Univ Med Sci - Level DNarrative ReviewEurope PMC
Cell-derived biomimetic drug delivery system for inflammatory bowel disease therapy
Narrative Review, published in Mater Today Bio (2024) — summary generated from the PubMed abstract.
- 2024
Mater Today Bio9 citations - Level CProspective StudyEurope PMC
Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy
Prospective Study with a reported sample of 11 on Immune Modulation, Autoimmune Research, published in Stem Cells Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
- n = 11
Stem Cells Transl Med8 citations - Level BClinical TrialEurope PMC
Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges
Clinical Trial on Chronic Inflammation, Autoimmune Research, published in J Inflamm Res (2023) — summary generated from the PubMed abstract.
- 2023
J Inflamm Res38 citations - Level DNarrative ReviewEurope PMC
Breathe easy: inhalational therapy for feline inflammatory airway disease
Narrative Review on Systemic / IV, published in J Feline Med Surg (2023) — summary generated from the PubMed abstract.
- 2023
J Feline Med Surg5 citations - Level DNarrative ReviewEurope PMC
Exosomes: Potential Next-Generation Nanocarriers for the Therapy of Inflammatory Diseases
Narrative Review on Osteoarthritis, Autoimmune Research, published in Pharmaceutics (2023) — summary generated from the PubMed abstract.
- 2023
Pharmaceutics24 citations - Level CProspective StudyEurope PMC
P354 Immunological response to vaccination against SARS-COV-2 infection in Inflammatory Bowel Disease patients under immunosuppressive therapy: should we prioritize an additional booster injection?
Prospective Study on Autoimmune Research, published in J Crohns Colitis (2022) — summary generated from the PubMed abstract.
- 2022
J Crohns Colitis - Level BClinical TrialPubMed
Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells.
Clinical Trial on Chronic Inflammation, Autoimmune Research, published in Int Immunopharmacol (2022) — summary generated from the PubMed abstract.
- 2022
Int Immunopharmacol - Level DNarrative ReviewEurope PMC
Oxytocin and Related Peptide Hormones: Candidate Anti-Inflammatory Therapy in Early Stages of Sepsis
Narrative Review on Chronic Inflammation, published in Front Immunol (2022) — summary generated from the PubMed abstract.
- 2022
Front Immunol24 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
Narrative Review on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Front Immunol (2022) — summary generated from the PubMed abstract.
- 2022
Front Immunol26 citations - Level BClinical TrialEurope PMC
Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease
Clinical Trial on Immune Modulation, Autoimmune Research, published in World J Stem Cells (2022) — summary generated from the PubMed abstract.
- 2022
World J Stem Cells8 citations - Level DNarrative ReviewEurope PMC
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update
Narrative Review on Autoimmune Research, published in Front Gastroenterol (Lausanne) (2022) — summary generated from the PubMed abstract.
- 2022
Front Gastroenterol (Lausanne) - Level ASystematic ReviewEurope PMC
Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review
Systematic Review on Autoimmune Research, published in Biomolecules (2021) — summary generated from the PubMed abstract.
- 2021
Biomolecules47 citations - Level DAnimal StudyPubMed
Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension.
Animal Study on Chronic Inflammation, published in Sci Rep (2021) — summary generated from the PubMed abstract.
- 2021
Sci Rep - Level DAnimal StudyPubMed
Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
Animal Study on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cell Res Ther - Level DNarrative ReviewPubMed
Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy.
Narrative Review on Chronic Inflammation, Immune Modulation, published in Mayo Clin Proc Innov Qual Outcomes (2020) — summary generated from the PubMed abstract.
- 2020
Mayo Clin Proc Innov Qual Outcomes - Level DLaboratory StudyEurope PMC
Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019
Laboratory Study on Autoimmune Research, published in J Int Med Res (2020) — summary generated from the PubMed abstract.
- 2020
J Int Med Res7 citations - Level DNarrative ReviewEurope PMC
Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy
Narrative Review on Immune Modulation, Autoimmune Research, published in World J Stem Cells (2020) — summary generated from the PubMed abstract.
- 2020
World J Stem Cells43 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
Narrative Review on Chronic Inflammation, Immune Modulation, published in World J Stem Cells (2020) — summary generated from the PubMed abstract.
- 2020
World J Stem Cells19 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406